Last year I engineered an advanced agentic AI pharma strategy development application.
One year later, after many illuminating discussions, the complexity of introducing such an offering became clear, and I decided that to shed more light I would produce a formal white paper based on a series of structured qualitative interviews with senior commercial leaders.
Here I set out the main findings with anonymised illustrative quotes drawn from the interviews and triangulate them with other published work by McKinsey, Bain, IBM, the World Economic Forum and others.
Check out the rest of the feature here
